
Industry professionals from the Food and Drug Administration (FDA), Bristol Myers Squibb (BMS), Pfizer, MilliporeSigma, Sanofi, Cytiva, UMass Biologics and UMass Lowell teach key principles and concepts of industrial bioprocessing of protein, cell/gene, mRNA therapies. The course covers recent technologies and practices of upstream, downstream, and analytical tools in the bioprocessing industry. In addition, regulatory filing, and FDA initiatives of Process Analytical Technology (PAT), Quality by Design, and Data Sciences will be covered.
For questions please email: bpqc@uml.edu or Seongkyu_Yoon@uml.edu.
We value inclusion and access for all participants and are pleased to provide reasonable accommodations for this event. Please contact this event’s organizer to make an accommodation request. (Please note: Requests submitted with less than 72 hours' notice may not be reasonable to provide certain accommodations).